Zydus Hiring For Biopharmaceutics and Clinical Development (Formulation R&D)
Zydus Hiring For Biopharmaceutics and Clinical Development (Formulation R&D) |
Inviting candidates for the post of Deputy Manager / Manager for Biopharmaceutics and Clinical Development (Formulation R&D) for Pharmaceutical Technology Centre, Ahmedabad
Biopharmaceutics and Clinical Development (Formulation R&D) Deputy Manager / Manager :
M.Pharm / PhD / M. Sc. in Pharmacology and Toxicology with 5-10 years of experience in clinical and preclinical development for Formulation R&D.
Candidates would be responsible for the following tasks-
Clinical and preclinical development of 505(b)(2) products:
• Literaturesearchfocusingonpreclinicalandclinicaldevelopmentprogrammes.
• Understanding and defining the rationale of unmet needs for identified product.
• Thorough understanding of disease physiology and preclinical safety pharmacology.
• Identifying appropriate CRO for conducting non-clinical POC, Toxicity, safety pharmacology studies, PK / PD studies in human and bioequivalence / bioavailability studies.
• Budgeting of preclinical and clinical studies.
• Authoring and reviewing of study plan, protocol, scientific justification and publication for non-clinical studies.
Candidates would also be responsible for the following tasks -
Clinical and preclinical development of 505(b)(2) products:
• Reviewing the data of preclinical POC, bioavailability and bioequivalence studies and leading the discussion with different cross functional teams and CROs.
• Authoring and reviewing of clinical, non-clinical sections in IND, briefing package, investigator’s brochure and NDA for regulatory submission.
• Monitoring preclinical and clinical studies in India and overseas CROs.
• Oversee local regulatory application submission and approvals.
Candidates would also be responsible for the following tasks –
Genotoxicity / Toxicity studies:
• Outsourcing and overseeing all technical and regulatory aspects of AMES test (invitro, invivo tissue distribution studies) and toxicity studies.
• Reviewing of study data, study report and defining the strategy for the assessment of genotoxicity/toxicity study as per USFDA, ICH and OECD guidance.
• Managing the budget and financial aspects of CROs.
Post a Comment